Autel Energy Europe Unveils Innovative AC and DC Charging Solutions at Partner Summit Europe 2025 in Paris and Reports Strong 2024 Growth
12.2.2025 10:15:00 CET | Business Wire | Press Release
Autel Energy Europe successfully hosted its Partner Summit Europe 2025 in Paris, bringing together leading industry experts, partners, and clients to explore the future of electric mobility. The event showcased Autel’s latest innovative charging solutions in both AC and DC. Autel also announced its strategic move into AI deployment, aimed at supporting the development of new energy products, solutions, and services, further enhancing its commitment to innovation in the electric mobility space.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250211851177/en/
Autel’s MaxiCharger AC and DC charging solutions on display (Photo: Business Wire)
In addition to unveiling its cutting-edge products, Autel shared its strong financial performance for 2024. Autel Energy Europe experienced significant growth, reflecting its leadership in the high-performance charging sector. The company continued to expand its presence across Europe, installing a substantial number of MaxiCharger DC and AC units, offering reliable and scalable charging solutions for commercial and urban applications. These achievements highlight Autel’s ongoing commitment to advancing electric mobility infrastructure across the region.
MaxiCharger MCS Dispenser II: Revolutionizing Megawatt Charging
Building on the success of its first-generation MaxiCharger Megawatt Charging System, Autel launched the MCS Dispenser II, now featuring an additional CCS socket for enhanced compatibility with electric trucks and commercial vehicles in mixed-fleet operations.
With improved cable management, the MCS Dispenser II offers greater flexibility in high-power charging environments. Delivering megawatt-level power, it reduces charging times, boosting fleet efficiency and vehicle uptime. The system is equipped with intelligent load balancing, advanced thermal management, and robust safety features, making it a future-proof solution for electrified transport.
MaxiCharger DH480: The 480kW All-in-One DC Charger
Autel’s modular-designed MaxiCharger DH480 480kW All-in-One DC Charger is built to meet the demand for ultra-fast EV charging across urban areas, commercial fleet depots, and highway service stations throughout Europe. Its flexible modular structure allows for easy deployment, seamless expansion, simplified maintenance, and scalability to support future growth.
MaxiCharger DS480 Distribution System
The MaxiCharger DS480 Distribution System provides a versatile power distribution solution for high-demand EV charging environments. Featuring uncooled dispensers with up to 320kW and liquid-cooled dispensers with up to 480kW, the system ensures reliability, high efficiency, and adaptability across a range of applications.
MaxiCharger AC Elite II: Advanced AC Charging
The AC Elite II offers smart, fast deployment with one-click installation and station level commissioning in just 10 minutes. It supports scalable charging networks with load balancing for up to 200 chargers and integrates seamlessly with PnC & ISO 15118-20 communication standards. Dual backup networks (WiFi and WI-SUN) ensure reliable operation with a 99% online rate.
About Autel Energy Europe
Autel Energy Europe provides innovative EV charging solutions that support the transition to sustainable mobility. With a strong presence in 22 European countries, Autel offers efficient, scalable, and sustainable charging infrastructure. Its range includes the versatile MaxiCharger AC series and high-performance DC fast chargers, designed for various applications from homes to commercial fleets, highways, and public networks.
For more information on Autel’s latest charging solutions, visit https://autelenergy.eu/
View source version on businesswire.com: https://www.businesswire.com/news/home/20250211851177/en/
Contacts
jiaqi.liu@autel.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Wyss Geneva Steps Into Its Next Chapter11.6.2026 13:33:00 CEST | Press Release
The Wyss Center for Bio and Neuroengineering in Geneva is pleased to announce the appointment of Dr. Tracy Laabs as Director, effective July 1st 2026. Dr. Laabs succeeds Prof. Dr. Erwin Böttinger, who leaves behind a fundamentally transformed organization: one that no longer just pursues breakthrough science but systematically turns it into ventures that reach patients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260611328520/en/ Dr. Tracy Laabs, incoming Director, Wyss Center Geneva Since joining the Wyss Center as Director in April 2023, Prof. Böttinger brought a bold vision: to evolve the Center from a portfolio of promising projects into a disciplined engine for venture creation. Under his leadership, the Center spun off six companies in two years (including ABILITY Neurotech SA and Clee Medical SA in 2025) while simultaneously building a robust pipeline of next-generation programs in AI-guided neuromodulation and min
BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit11.6.2026 13:24:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced the presentation of a large Phase 3 dataset in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) aged 80 and older, showing sustained benefit with BRUKINSA after nearly 6.5 years of follow-up, reinforcing its role as the foundational BTK inhibitor. BRUKINSA is the only BTK inhibitor to demonstrate superior efficacy vs. ibrutinib in a Phase 3 trial.1 These data, one of the largest datasets of older patients with treatment-naive CLL, will be presented at the 2026 European Hematology Association (EHA) Congress in Stockholm, Sweden. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: "While the median age of diagnosis for CLL is 70 and the average age of treatment initiation is 75, many pivotal trials still underrepresent the patients that physicians most often see in practice. These data show that the durable benefit of
Takeda’s Zasocitinib Significantly Outperforms Deucravacitinib in Head-to-Head Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations11.6.2026 13:00:00 CEST | Press Release
Takeda (TSE:4502/NYSE:TAK) announced positive topline results for the Phase 3, randomized, multicenter, double-blind study comparing zasocitinib (TAK-279), an investigational, next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, to deucravacitinib in adults with moderate-to-severe plaque psoriasis (PsO). In the LATITUDE Atlas (TAK-279-PsO-3004) head-to-head study, zasocitinib demonstrated statistical superiority over deucravacitinib for the primary endpoint, Psoriasis Area and Severity Index (PASI) 100 response rate at week 16. The study also demonstrated statistical superiority over deucravacitinib for all key secondary endpoints, including PASI 90 response and Static Physician's Global Assessment (sPGA) 0 at week 16. Zasocitinib was generally well tolerated with a consistent safety and tolerability profile and no new safety signals identified. Perspectives on head-to-head zasocitinib study “In this head-to-head study, zasocitinib clearly demonstrated
Clearlake Expands Liquid Credit Platform With Acquisition of LCM Asset Management’s CLO Contracts11.6.2026 13:00:00 CEST | Press Release
Clearlake Capital Group, L.P. (“Clearlake” or the “Firm”), a global investment firm managing integrated platforms spanning private equity, liquid and private credit, and other related strategies, today announced that its credit platform, Clearlake Credit, will assume management of CLOs managed by LCM Asset Management, LLC. The transaction adds 31 CLOs representing more than $5 billion of assets under management and increases assets managed by Clearlake Credit to approximately $39 billion across liquid credit, private credit, and other customized credit solutions. The acquisition further broadens the Firm’s capabilities, deepens its relationships with institutional investors, and reinforces its client-centric approach and commitment to seeking attractive risk-adjusted returns across market cycles. Milbank LLP and Dechert LLP represented Clearlake Credit in the transaction. GreensLedge Capital Markets advised the seller. About Clearlake Clearlake Capital is a leading global alternative a
L&T Technology Services, Databricks Partner to Deliver Industrial AI at Scale for Asset-Intensive Industries11.6.2026 12:30:00 CEST | Press Release
L&T Technology Services (BSE: 540115, NSE: LTTS), a global leader in AI, Digital & ER&D Consulting Services, today announced a strategic go-to-market partnership with Databricks, the leading Data and AI company, to co-develop and deliver Industrial AI solutions that advance Engineering Intelligence (EI) for asset-intensive enterprises. Anchored in LTTS' Sustainability segment, spanning Process Engineering, Discrete Manufacturing and Industrial Products, the partnership will support Energy, Petrochemicals and Industrials clients globally. As industrial organizations seek to unlock greater value from decades of operational and engineering data, the alliance will combine LTTS’ deep domain capabilities with the Databricks platform to transform complex plant data into Engineering Intelligence - enabling improved asset reliability, operational efficiency and sustainability performance. The partnership brings together LTTS’ expertise in forward looking technologies and extensive experience ac
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom